Up­dat­ed: Tale of two ‘Abs’: Ab­b­Vie part­ners with an­ti­body biotech Ab­Cellera, but keeps de­tails un­der wraps

Ab­b­Vie has signed a mul­ti-year deal with Van­cou­ver-based an­ti­body biotech Ab­Cellera, it an­nounced Thurs­day morn­ing.

How­ev­er, out­side of that, the duo gave few de­tails about …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER